Conserving blood cuts transfusions in aortic valve surgery

Conserving blood cuts transfusions in aortic valve surgery

(HealthDay)—A blood conservation strategy (BCS) reduces red blood cell (RBC) transfusions in patients undergoing aortic valve replacement (AVR) without increasing mortality or morbidity, according to research published in the January issue of the Annals of Thoracic Surgery.

David W. Yaffee, M.D., of the New York University Langone Medical Center in New York City, and colleagues retrospectively reviewed the records of patients undergoing AVR before (391 patients) and after (387 patients) enactment of BCS at a single institution.

The researchers found that the incidence of RBC transfusion decreased significantly from 82.9 percent in the pre-BCS group to 68.0 percent in the post-BCS group. No difference was observed in the rates of mortality or major complications between the groups. Patients receiving isolated AVR and also were less likely to have transfusions. RBC transfusion of two or more units on the day of operation was significantly associated with increased mortality, prolonged intubation, postoperative renal failure, and increased incidence of any complication.

"The Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists clinical practice guidelines for blood conservation in routine cardiac surgery should be extended to AVR patients," the authors write. "Decreased blood product utilization can be effected in AVR patients by limiting hemodilution, tolerating perioperative anemia, and educating the cardiac surgical care providers on blood management."

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Blood transfusions in cardiac surgery may up infections

date Jun 05, 2013

(HealthDay)—Transfusion of red blood cells (RBCs) during or after surgery may increase the risk of major infections, such as pneumonia and bloodstream infections, according to research published in the ...

Poorer outcomes after non-cardiac surgery in DM

date Sep 11, 2013

(HealthDay)—For patients undergoing non-cardiac surgery, diabetes is associated with adverse perioperative complications and mortality, according to a study published online Aug. 29 in Diabetes Care.

Recommended for you

1950s drug is future heart treatment

date 23 hours ago

Oxford University researchers have found a promising future treatment for heart disease, going back to a drug first developed in 1950.

Time is muscle in acute heart failure

date May 21, 2015

Urgent diagnosis and treatment in acute heart failure has been emphasised for the first time in joint recommendations published today in European Heart Journal.

Common mutation linked to heart disease

date May 20, 2015

A common mutation in a gene that regulates cholesterol levels may raise the risk of heart disease in carriers, according to a new UConn Health study.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.